We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Halts Phase 3 Vaccine Trial Over Possible Serious Adverse Reaction
AstraZeneca Halts Phase 3 Vaccine Trial Over Possible Serious Adverse Reaction
AstraZeneca has paused a late-stage trial of its promising COVID-19 vaccine candidate while it evaluates a single UK patient who may have experienced a serious adverse reaction.